MolecuLight Named Global Company of the Year
Frost & Sullivan honors the wound imaging firm for its achievements in innovation and clinical leadership.
Updated on Oct. 28, 2026 in Healthcare
MolecuLight has received the 2026 Global Company of the Year Award in the wound imaging industry. The accolade recognizes the company for its leadership and customer experience.
Why it matters
The award highlights companies that show exceptional achievement in innovation. This recognition underscores the growing industry emphasis on advanced digital wound care technologies.
MolecuLight supports the clinical utility of its technologies with more than 100 peer-reviewed publications. The company maintains SOC 2 Type II and FIPS certifications for its imaging operations.
The players
MolecuLight
A developer of handheld wound imaging systems that utilize bacterial fluorescence and digital measurement technologies.
Frost & Sullivan
A global research and consulting firm that benchmarks companies through deep-dive analysis, secondary research, and industry interviews.
The details
MolecuLight produces the FDA-cleared i:X and DX systems, which combine bacterial fluorescence imaging, digital wound measurement, and thermal imaging. Their DX+ platform further integrates thermal imaging capabilities into a single handheld device.
Timeline
October 28, 2026: MolecuLight announced receiving the award.
Market Landscape
The 2026 Frost & Sullivan Global Company of the Year Award sets a standard for innovation within the diagnostic medical device sector. This recognition positions MolecuLight as a leader against competitors by validating the clinical efficacy of its specialized imaging hardware.
This award reinforces the clinical reliability of the diagnostic tools used in wound care facilities. For patients in Pittsburgh, it signifies that local providers utilizing these systems are using industry-validated technology.
The takeaway
Clinicians and healthcare facilities often look to industry benchmarks to guide their technology investments. Prioritizing platforms with extensive peer-reviewed backing can improve consistency in diagnostic outcomes.
Further reading
Learn more about the latest innovations in Healthcare.
Source note: This article includes information reported by Adnkronos.
